APA (7th ed.) Citation

Galeano, K., Culbreth, R. E., Brent, J., Amaducci, A., Falise, A. M., Zmuda, A. G., . . . Mircea-Catalin, F. (2026). The Selection of Andexanet Alfa vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage. Journal of Clinical Pharmacy & Therapeutics, 2026, 1. https://doi.org/10.1155/jcpt/3950388

Chicago Style (17th ed.) Citation

Galeano, Kira, et al. "The Selection of Andexanet Alfa Vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage." Journal of Clinical Pharmacy & Therapeutics 2026 (2026): 1. https://doi.org/10.1155/jcpt/3950388.

MLA (9th ed.) Citation

Galeano, Kira, et al. "The Selection of Andexanet Alfa Vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage." Journal of Clinical Pharmacy & Therapeutics, vol. 2026, 2026, p. 1, https://doi.org/10.1155/jcpt/3950388.